{"id":"W3030666284","doi":"10.1200/jco.19.03158","title":"Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Atezolizumab; Bevacizumab; Carboplatin; Lung cancer; Internal medicine; Adverse effect; Oncology; Paclitaxel; Chemotherapy; Population; Clinical endpoint; Cancer; Surgery; Clinical trial; Nivolumab; Cisplatin; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003218353,0.0003672608,0.001074034,0.0003175905,0.0001488593,0.0004956425,0.0003144443,0.0005417818,0.00124563],"category_scores_gemma":[0.005165398,0.0001239122,0.001712118,0.000292934,0.0003248512,0.0005268491,0.0002457113,0.001126962,0.0001646457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004465624,"about_ca_system_score_gemma":0.0004377192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002023782,"about_ca_topic_score_gemma":0.0004561644,"domain_scores_codex":[0.9979854,0.001168868,0.0002362719,0.0001950806,0.0003177048,0.00009676411],"domain_scores_gemma":[0.9961687,0.001192301,0.001948274,0.000130656,0.0002230947,0.0003369586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7264225,0.009204171,0.05711116,0.002299453,0.007572932,0.0001389727,0.0001312291,0.003517546,0.009687743,0.0001711694,0.001432494,0.1823107],"study_design_scores_gemma":[0.1288444,0.6045037,0.2364575,0.0003809183,0.007744596,0.0006910659,0.0001387981,0.008742698,0.008124934,0.0005109035,0.003782126,0.000078478],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929205,0.00488444,0.0003598968,0.0002356532,0.0000895269,0.000222545,0.000533653,0.00001711229,0.0007368297],"genre_scores_gemma":[0.9979176,0.0007747179,0.0002429966,0.0001798653,0.00006926011,0.0002001333,0.0003956565,0.000002878768,0.0002168841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003218353,"threshold_uncertainty_score":0.01702046,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06888573817441451,"score_gpt":0.4097461346332562,"score_spread":0.3408603964588417,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}